Business
PNDX_B: Revenue and NOI rose in Q3, with Dalata acquisition to drive further growth in 2026
PNDX_B: Revenue and NOI rose in Q3, with Dalata acquisition to drive further growth in 2026
About this update from Pandox Ab Class B
Q3 2025 saw revenue and NOI growth driven by acquisitions and strong Nordic demand, with the Dalata acquisition set to boost results from Q4 and 2026. Loan-to-value remains healthy, and the portfolio is well-diversified, while currency headwinds and one-off transaction costs are noted.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.